According to numerous research, AQP5 expression levels are directly correlated with tumour stage, lymph node metastases, and poor diagnosis, suggesting that AQP5 may be used as a potential biomarker for ovarian cancer [154]. The gene discussed is AQP5; the disease is neoplasm.